Send us a text

Join Dr. Michael Koren as he sits down with Dr. Doug Denham, a Certified Principal Investigator with extensive experience in family medicine and obesity research for the first of this two part series as they discuss the lengthy process of becoming a Certified Principal Investigator. The doctors discuss new obesity medications that are being investigated through clinical research and how difficult it can be to retain patients who aren't reaching their weight loss goals in an obesity study.

Doctors Koren and Denham discuss patient engagement and compliance and explore strategies that keep participants motivated throughout the trial process. They talk about the importance of personal connection in maintaining participant interest, revealing how understanding individual motivators can significantly impact scientific success. Dr. Denham emphasizes the importance of retaining participants for essential endpoint visits, even if they choose to stop taking the investigational product.

Learn about the benefits of offering open-label treatments post-unblinding, which can help patients even after an initial study has completed.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!